{"id":7739,"date":"2026-09-18T03:11:43","date_gmt":"2026-09-17T19:11:43","guid":{"rendered":"https:\/\/qualia-bio.com\/blog\/how-should-buyers-define-shutdown-and-installation-constraints-before-a-crabs-retrofit\/"},"modified":"2026-09-18T03:11:44","modified_gmt":"2026-09-17T19:11:44","slug":"how-should-buyers-define-shutdown-and-installation-constraints-before-a-crabs-retrofit","status":"publish","type":"post","link":"https:\/\/qualia-bio.com\/tr\/blog\/how-should-buyers-define-shutdown-and-installation-constraints-before-a-crabs-retrofit\/","title":{"rendered":"Al\u0131c\u0131lar, bir cRABS yenileme \u00e7al\u0131\u015fmas\u0131ndan \u00f6nce kesinti ve kurulum k\u0131s\u0131tlamalar\u0131n\u0131 nas\u0131l tan\u0131mlamal\u0131d\u0131r?"},"content":{"rendered":"<p>cRABS modernizasyon kesintisi kapsam\u0131nda kurulum planlamas\u0131 bir tedarik\u00e7i takvimine d\u00f6n\u00fc\u015ft\u00fcr\u00fclmeden \u00f6nce, al\u0131c\u0131 ve tedarik\u00e7inin \u015fantiye k\u0131s\u0131tlamalar\u0131n\u0131 tedarik\u00e7inin i\u015f varsay\u0131mlar\u0131ndan ay\u0131rmas\u0131 gerekir. Bir tedarik\u00e7i kurulum faaliyetlerini \u00f6nerebilir, ancak proje bu kararlar\u0131 kendisine atamad\u0131k\u00e7a, \u00fcretimin ne zaman ba\u015flat\u0131laca\u011f\u0131n\u0131, hangi g\u00fczerg\u00e2hlar\u0131n a\u00e7\u0131k kalaca\u011f\u0131n\u0131 veya yeniden ba\u015flatmay\u0131 kimin onaylayaca\u011f\u0131n\u0131 belirleyemez. Buradan elde edilecek yararl\u0131 \u00e7\u0131kt\u0131, genel bir kesinti s\u00fcresi de\u011fil, bir k\u0131s\u0131tlama kayd\u0131 ve bir ba\u011f\u0131ml\u0131l\u0131k zinciridir.<\/p>\n<h2 id=\"mapproductionwindowsandsiteaccessconstraints\">Harita Haz\u0131rlama Zaman Aral\u0131\u011f\u0131 ve Saha Eri\u015fimi K\u0131s\u0131tlamalar\u0131<\/h2>\n<p>\u0130zin verilen kesinti zaman aral\u0131klar\u0131n\u0131, hat ve oda kullan\u0131labilirli\u011fini, malzeme ve personel g\u00fczerg\u00e2hlar\u0131n\u0131, \u015fantiyede bilinen kald\u0131rma veya haz\u0131rl\u0131k s\u0131n\u0131rlamalar\u0131n\u0131, eri\u015fim kontrol\u00fc k\u0131s\u0131tlamalar\u0131n\u0131 ve birbiriyle \u00e7ak\u0131\u015fmamas\u0131 gereken faaliyetleri belirleyin. Bunlar\u0131, genel kesinti s\u00fcreleri veya kurulum y\u00f6ntemleri olarak de\u011fil, al\u0131c\u0131 taraf\u0131ndan belirtilen k\u0131s\u0131tlamalar olarak de\u011ferlendirin.<\/p>\n<table>\n<thead>\n<tr>\n<th>K\u0131s\u0131tlama grubu<\/th>\n<th>Al\u0131c\u0131 taraf\u0131ndan belirtilen durum<\/th>\n<th>Proje karar\u0131 etkilendi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u00dcretim kapasitesi<\/td>\n<td>\u00c7ak\u0131\u015fmamas\u0131 gereken izin verilen kesinti zaman aral\u0131klar\u0131 ve faaliyetler<\/td>\n<td>\u015eantiye \u00e7al\u0131\u015fmalar\u0131n\u0131n ne zaman planlanabilece\u011fi<\/td>\n<\/tr>\n<tr>\n<td>Oda ve hat eri\u015fimi<\/td>\n<td>\u0130zin verilen giri\u015f g\u00fczerg\u00e2hlar\u0131, \u00e7al\u0131\u015fma alanlar\u0131 ve eri\u015fim k\u0131s\u0131tlamalar\u0131<\/td>\n<td>Ekipman ve personelin kurulum alan\u0131na nas\u0131l ula\u015fabilece\u011fi<\/td>\n<\/tr>\n<tr>\n<td>Sahneleme ve hareket<\/td>\n<td>Bilinen teslimat, depolama ve elle\u00e7leme s\u0131n\u0131rlar\u0131<\/td>\n<td>\u00d6nerilen kurulum yolunun daha ayr\u0131nt\u0131l\u0131 bir incelemeye tabi tutulmas\u0131 gerekip gerekmedi\u011fi<\/td>\n<\/tr>\n<tr>\n<td>Ba\u011flant\u0131 Haz\u0131rl\u0131\u011f\u0131<\/td>\n<td>Onaylanm\u0131\u015f hizmet, hava, kontrol ve yap\u0131sal aray\u00fczlerin mevcut olmas\u0131<\/td>\n<td>Kesinti s\u00fcresince hangi ba\u011flant\u0131lar planlanabilir?<\/td>\n<\/tr>\n<tr>\n<td>Serbest b\u0131rak\u0131lma ko\u015fullar\u0131<\/td>\n<td>Tesis taraf\u0131ndan belirlenen temizlik, kontroller, kay\u0131tlar ve onaylar<\/td>\n<td>Kullan\u0131ma yeniden ba\u015flanmadan \u00f6nce nelerin tamamlanmas\u0131 gerekir?<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Proje kapsam\u0131 i\u00e7in ilgili ekipman referans\u0131 \u015fudur: <a href=\"https:\/\/qualia-bio.com\/tr\/product\/isoseries\/closed-restricted-access-barrier-system-crabs\/\">Kapal\u0131 K\u0131s\u0131tl\u0131 Eri\u015fim Bariyer Sistemi - cRABS<\/a>; bu ba\u011flant\u0131 bir gezinme ba\u011flant\u0131s\u0131d\u0131r; program, y\u00f6ntem a\u00e7\u0131klamas\u0131 veya kurulum garantisi de\u011fildir. A\u015fa\u011f\u0131da a\u00e7\u0131klanan kurulum a\u015famas\u0131ndaki ba\u011f\u0131ml\u0131l\u0131klar <a href=\"https:\/\/qualia-bio.com\/tr\/blog\/crabs-installation-expert-services-for-pharma\/\">cRABS Kurulumu: Pharma i\u00e7in Uzman Hizmetler<\/a> Bu, al\u0131c\u0131lar\u0131n neleri kapatma ve eri\u015fim k\u0131s\u0131tlamalar\u0131na d\u00f6n\u00fc\u015ft\u00fcreceklerini belirlemelerine yard\u0131mc\u0131 olabilir, ancak site yine de izin verilen ger\u00e7ek zaman aral\u0131klar\u0131n\u0131 sunmaktad\u0131r.<\/p>\n<h2 id=\"linkinstallationactivitiestocleanroomandequipmentchangeimpact\">Kurulum Faaliyetlerini Temiz Oda ve Ekipman De\u011fi\u015fikli\u011finin Etkileriyle \u0130li\u015fkilendirin<\/h2>\n<p>\u00d6nerilen her bir cRABS yenileme faaliyeti i\u00e7in, bunun temiz oday\u0131, \u00fcretim hatt\u0131n\u0131, hava ak\u0131\u015f\u0131n\u0131, y\u00fczeyleri, kontrol sistemlerini veya izlenen durumu etkileyip etkilemeyece\u011fini belirleyin. <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdf\">AB GMP Ek 1<\/a> Bu, ekipman, tesis, s\u00fcre\u00e7 ve HVAC de\u011fi\u015fikliklerinin de\u011fi\u015fiklik de\u011ferlendirmesini ve uygun yeniden onay s\u00fcrecini tetikleyebilece\u011fini belirtir; bu da etki de\u011ferlendirmesini evrensel bir do\u011frulama paketi olmaktan ziyade projeye \u00f6zg\u00fc bir konu haline getirir.<\/p>\n<p>Temiz oda s\u0131n\u0131rlar\u0131n\u0131 a\u015fan veya hava ak\u0131\u015f\u0131n\u0131, y\u00fczeyleri, kontrol sistemlerini ya da izlenen durumu de\u011fi\u015ftiren \u00f6nerilen \u00e7al\u0131\u015fmalar, tesisin de\u011fi\u015fiklik s\u00fcreci kapsam\u0131nda ele al\u0131nmal\u0131 ve etki de\u011ferlendirmesi sonucunda yeniden kalifikasyonun uygun olup olmad\u0131\u011f\u0131 belirlenmelidir. Ek 1\u2019de cRABS kurulum s\u0131ras\u0131, kapatma s\u00fcresi, y\u00fcklenici y\u00f6ntemi, proje test paketi, sorumluluk da\u011f\u0131l\u0131m\u0131 veya yeniden ba\u015flatma onay\u0131 konusunda herhangi bir kural belirtilmemi\u015ftir.<\/p>\n<h2 id=\"sequenceinstallationreassemblyandrequiredconfirmation\">S\u0131ra, Montaj, Yeniden Birle\u015ftirme ve Gerekli Onay<\/h2>\n<p>Site teslimat\u0131 ve giri\u015f eri\u015fiminden ba\u015flayarak kurulum, ba\u011flant\u0131, yeniden montaj, temizlik, projeye \u00f6zg\u00fc kontroller ve yetkili kullan\u0131m izni a\u015famalar\u0131n\u0131 kapsayan bir ba\u011f\u0131ml\u0131l\u0131k zinciri olu\u015fturun. <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdf\">AB GMP Ek 1<\/a> ekipman kurulumunda bak\u0131m ve onar\u0131mlar\u0131n dikkate al\u0131nmas\u0131 gerekti\u011fini ve yeniden montaj, temizlik, dezenfeksiyon, izleme ve tekrar kullan\u0131ma al\u0131nman\u0131n etkilerinin \u00f6nemli olabilece\u011fini belirtmektedir.<\/p>\n<p>Bu ak\u0131\u015f \u015femas\u0131 evrensel bir y\u00f6ntem a\u00e7\u0131klamas\u0131 de\u011fildir; bir sonraki faaliyetin hangi \u00f6nc\u00fcl, kan\u0131t ve serbest b\u0131rakma karar a\u015famalar\u0131na ba\u011fl\u0131 oldu\u011funu ortaya koyman\u0131n bir yoludur. Ba\u011flant\u0131 haz\u0131rl\u0131\u011f\u0131 veya temizlik kararlar\u0131 hen\u00fcz kesinle\u015fmemi\u015fse, kurulum program\u0131 ancak \u015fartl\u0131 olabilir. Mevcut hat entegrasyon planlamas\u0131 <a href=\"https:\/\/qualia-bio.com\/tr\/blog\/integrating-crabs-upgrade-your-pharma-production-line\/\">cRABS Entegrasyonu: \u0130la\u00e7 \u00dcretim Hatt\u0131n\u0131z\u0131 Y\u00fckseltin<\/a> bu zincirle uyumlu hale getirilmelidir; zira tedarik\u00e7inin kurulum faaliyetleri, tedarik\u00e7inin kontrol\u00fc d\u0131\u015f\u0131nda kalan hat ko\u015fullar\u0131na ve \u015fantiyedeki onay a\u015famalar\u0131na ba\u011fl\u0131 olabilir.<\/p>\n<h2 id=\"turnscheduleassumptionsintosupplierboundaries\">\u00c7al\u0131\u015fma Program\u0131 Varsay\u0131mlar\u0131n\u0131 Tedarik\u00e7i S\u0131n\u0131rlar\u0131na D\u00f6n\u00fc\u015ft\u00fcr\u00fcn<\/h2>\n<p>Eri\u015fim, izolasyon, izinler, \u00e7izimler, \u015febekeye ba\u011flanma haz\u0131rl\u0131\u011f\u0131, temizlik kararlar\u0131, test deste\u011fi, kay\u0131tlar ve devreye alma kararlar\u0131n\u0131 kimin sa\u011flad\u0131\u011f\u0131n\u0131 belirtin. Bir tedarik\u00e7i program\u0131, tedarik\u00e7inin i\u015f kapsam\u0131 dahilindeki faaliyetleri ve s\u00fcreleri tan\u0131mlayabilir; ancak proje bu yetkiyi a\u00e7\u0131k\u00e7a vermedik\u00e7e, \u015fantiye kararlar\u0131n\u0131 atayamaz veya hatt\u0131n yeniden devreye al\u0131nmas\u0131na izin veremez.<\/p>\n<p><a href=\"https:\/\/store.astm.org\/e2500-25.html\">ASTM E2500-25<\/a> Mevcut ila\u00e7 \u00fcretim sistemlerinde de\u011fi\u015fiklik yap\u0131ld\u0131\u011f\u0131nda, ama\u00e7lanan kullan\u0131m\u0131n teknik \u015fartname, tasar\u0131m, kurulum, i\u015fletim, performans ve do\u011frulama ile ili\u015fkilendirilmesini destekler. \u00d6zet k\u0131sm\u0131nda kesinti planlamas\u0131, in\u015faat kontrolleri, FAT\/SAT tahsisi, kabul kriterleri veya bir hatt\u0131n yeniden hizmete al\u0131nmas\u0131na ili\u015fkin yetki tan\u0131mlanmam\u0131\u015ft\u0131r. Bunu, bir sorumluluk matrisi veya yeniden ba\u015flatma onay\u0131 olarak de\u011fil, ama\u00e7lanan kullan\u0131m etraf\u0131nda do\u011frulama sorular\u0131n\u0131 d\u00fczenlemek i\u00e7in kullan\u0131n. S\u0131n\u0131r kayd\u0131, her bir k\u0131s\u0131tlama i\u00e7in bilgi sa\u011flay\u0131c\u0131y\u0131, karar sahibini, i\u015fin y\u00fcr\u00fct\u00fcc\u00fcs\u00fcn\u00fc ve serbest b\u0131rakma onaylay\u0131c\u0131s\u0131n\u0131 ay\u0131rt etmelidir; bunlar\u0131n netle\u015ftirilmedi\u011fi durumlarda, planlama varsay\u0131mlar\u0131 ge\u00e7ici olarak kal\u0131r.<\/p>\n<h2 id=\"frequentlyaskedquestions\">S\u0131k\u00e7a Sorulan Sorular<\/h2>\n<p><strong>Q:<\/strong> Yenileme kurulum takvimi talebinde bulunmadan \u00f6nce neleri haz\u0131rlamal\u0131y\u0131z?<br \/>\n<strong>A:<\/strong> \u0130zin verilen kesinti zaman aral\u0131klar\u0131n\u0131, oda ve hat kullan\u0131labilirli\u011fini, eri\u015fim yollar\u0131n\u0131, haz\u0131rl\u0131k alan s\u0131n\u0131rlar\u0131n\u0131 ve birbiriyle \u00e7ak\u0131\u015fmamas\u0131 gereken faaliyetleri belirtin. Tedarik\u00e7inin kullan\u0131labilir \u00e7al\u0131\u015fma zaman aral\u0131klar\u0131n\u0131 \u00e7\u00f6z\u00fclmemi\u015f ba\u011f\u0131ml\u0131l\u0131klardan ay\u0131rt edebilmesi i\u00e7in hava, altyap\u0131, kontrol ve yap\u0131sal aray\u00fczlerin haz\u0131rl\u0131k durumunu da ekleyin.<\/p>\n<p><strong>Q:<\/strong> Kurulum \u00e7al\u0131\u015fmalar\u0131n\u0131n sona ermesi civar\u0131nda \u00fcretimin yeniden ba\u015flamas\u0131n\u0131 planlayabilir miyiz?<br \/>\n<strong>A:<\/strong> Programda, tesisin yeniden kullan\u0131ma a\u00e7\u0131lma ko\u015fullar\u0131 da dikkate al\u0131nmal\u0131d\u0131r. Yeniden montaj, temizlik, gerekli kontroller, kay\u0131tlar ve devreye alma kararlar\u0131 fiziksel kurulumdan sonra da devam edebilece\u011finden, \u00fcretim ba\u015flang\u0131\u00e7 tarihini belirlemeden \u00f6nce bu ba\u011f\u0131ml\u0131l\u0131klar\u0131 tespit edin.<\/p>\n<p><strong>Q:<\/strong> Oda veya hat \u00fczerindeki de\u011fi\u015fiklikler, kapatma planlamas\u0131n\u0131 nas\u0131l etkiler?<br \/>\n<strong>A:<\/strong> Projeye \u00f6zg\u00fc de\u011ferlendirme ve do\u011frulama \u00e7al\u0131\u015fmalar\u0131n\u0131 ekleyebilirler. Ekipman, y\u00fczeyler, hava ak\u0131m\u0131, HVAC sistemi, kontrol sistemleri ve izleme sistemleri \u00fczerindeki etkileri belirleyerek, \u015fantiyenin hangi de\u011fi\u015fiklik de\u011ferlendirmesinin veya yeniden yeterlilik de\u011ferlendirmesinin uygun oldu\u011funa karar vermesini ve bunu programa dahil etmesini sa\u011flarlar.<\/p>\n<p><strong>Q:<\/strong> Bir tedarik\u00e7i program\u0131n\u0131n, a\u00e7\u0131k\u00e7a dile getirilmemi\u015f \u015fantiye varsay\u0131mlar\u0131na dayanmas\u0131n\u0131 nas\u0131l \u00f6nleyebiliriz?<br \/>\n<strong>A:<\/strong> Her bir \u00f6n ko\u015fulu a\u00e7\u0131k\u00e7a belirtin ve sorumluluk s\u0131n\u0131rlar\u0131n\u0131 kararla\u015ft\u0131r\u0131n. Eri\u015fim, izolasyon, izinler, \u00e7izimler, ba\u011flant\u0131 haz\u0131rl\u0131\u011f\u0131, temizlik kararlar\u0131, test deste\u011fi, kay\u0131tlar ve onay kararlar\u0131n\u0131 kimin sa\u011flayaca\u011f\u0131n\u0131 listeleyin; bunlar\u0131n hepsinin kurulum kapsam\u0131na dahil oldu\u011funu varsaymay\u0131n.<\/p>","protected":false},"excerpt":{"rendered":"<p>Bir cRABS yenileme konseptini proje program\u0131na d\u00f6n\u00fc\u015ft\u00fcrmeden \u00f6nce \u00fcretim aral\u0131klar\u0131n\u0131, sahaya eri\u015fimi, kurulum aray\u00fczlerini, yeniden montaj\u0131, temizli\u011fi ve do\u011frulama ba\u011f\u0131ml\u0131l\u0131klar\u0131n\u0131 tan\u0131mlay\u0131n.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"n8n_meta_description":"","footnotes":""},"categories":[21],"tags":[],"class_list":["post-7739","post","type-post","status-publish","format-standard","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts\/7739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/comments?post=7739"}],"version-history":[{"count":1,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts\/7739\/revisions"}],"predecessor-version":[{"id":7740,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/posts\/7739\/revisions\/7740"}],"wp:attachment":[{"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/media?parent=7739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/categories?post=7739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qualia-bio.com\/tr\/wp-json\/wp\/v2\/tags?post=7739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}